Regenerative medicine and cell therapy
5 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- SERVICIO MADRILENO DE SALUD
Madrid's regional health service — a major European clinical trial site and patient recruitment hub across 67 H2020 health research projects.
“Clinical sites for RESSTORE (stroke stem cell therapy), SEPCELL (sepsis stem cells), ReGenHeart (cardiovascular gene therapy), ORTHOUNION (bone marrow MSCs), and ALIVER (liver dialysis).”
PrimaryES67 projects - KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)
TU Munich's university hospital: translational research in oncology, neuroscience, and precision diagnostics with strong ERC track record and advanced imaging capabilities.
“TETRA (tissue-engineered trachea with stem cells), BIOCARD (cardiac development modeling), and related ATMP work show capability in advanced therapy medicinal products.”
DE49 projects - CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER
Major French university hospital contributing clinical trials, patient cohorts, and translational research in diabetes, regenerative medicine, and digital health outcomes.
“Coordinated RESPINE (MSC therapy for disc disease, their largest project at EUR 933K) and participated in ADIPOA2 (adipose-derived stromal cell therapy).”
PrimaryFR12 projects - FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO
Milan's leading IRCCS teaching hospital contributing clinical trials, patient cohorts, and translational expertise in regenerative medicine, autoimmunity, and neurodegeneration.
“LSFM4LIFE (pancreas organoids for diabetes), ORTHOUNION (bone marrow MSC trials), and CROSS-NEUROD (iPSC-derived 3D models for neurodegeneration) all center on stem cell and organoid-based approaches.”
PrimaryIT10 projects - A2F ASSOCIATES LIMITED
UK SME specializing in cardiovascular gene therapy and regenerative medicine support within large European health research consortia.
“BOOSTB4 (mesenchymal stem cells for osteogenesis imperfecta) and ReGenHeart (regenerative VEGF-D therapy) demonstrate depth in regenerative approaches.”
PrimarySMEUK5 projects